Proxim Europe, Inc

Drug Royalty LP, based in Wilmington, DE, specializes in pharmaceutical royalty monetization by building a diversified portfolio that focuses on medicines addressing unmet medical needs. With a commitment to creating value, the company actively sources royalty streams from important drugs that have long-term patent protection and significant growth potential. Positioned as a best-in-class partner for both investors and innovators, Drug Royalty LP offers unique and flexible structures tailored to meet the needs of their counterparties. Their investment strategy aims to provide risk-mitigated exposure across multiple therapeutic areas, generating attractive returns and sustainable growth for stakeholders. Generated from the website